temozolomide - Globe Thesis

Keyword [temozolomide] Result: 161 - 180 \| Page: 9 of 10
161.	A Multimodality MRI Study Of Treatment Response Assessment In Patients With Glioma
162.	Long Noncoding RNA AC003092.1 Regulate Temozolomide Resistance Through MiR-195/TFPI2 Signaling Pathway In Glioblastoma
163.	Self-assembled Angiopep-2 Modified Lipid-poly(hypoxic Radiosensitized Polyprodrug)nanoparticles Delivery Temozolomide For Glioma Synergistic Temozolomide And Radiation Therapy
164.	ALKBH5 Mediated Long Noncodimg RNA SOX2OT Promotes SOX2 Expression And Regulates Temozolomide Resistance In Glioma
165.	The Effects And Mechanisms Of ?-catenin On Cordycepin Induced MGMT Inhibition And Reduction Of Temozolomide Resistance In Glioma Cells
166.	Combination Of 3-Methyladenine Therapy And ASN-Gly-Arg(NGR)-Modified Mesoporous Silica Nanoparticles Loaded With Temozolomide For Glioma Therapy
167.	Up-regulation Of MiR-497 Confers Resistance To Temozolomide In Human Glioma Cells By Targeting MTOR/Bcl-2
168.	The Role Of FOXM1 In Brain Glioma Growth And Drug Resistance
169.	Therapeutic Effects Of PLGA Nanoparticles Loaded With Antisense MiRNA-21 And Temozolomide On Glioma
170.	Mechanism Of Autophagic Flux Impairment Increased Sensitivity Of Temozolomide In Glioma Cells Through Non-canonical Activation Of Caspase-8
171.	The Effects Of MicroRNA-519a In Biological Behavior And Temozolomide Chemosensitivity Of GBM Cells
172.	The Study Of Mechanism Of Autophagy Inhibition By TOPK Phosphorylating ULK1 To Promote Glioma Resistance To TMZ
173.	The Study Of WGCNA Screens Out Oncogene RUVBL1 And Galangin Exerts Anti-glioblastoma Effect And Mechanism
174.	The Role Of Fstl1/DIP2A/FOS Signaling Pathway In Glioma Proliferation And Drug Resistance
175.	The Role Of Extracellular Vesicles In The Malignant Phenotype Of Glioma And Temozolomide Resistance
176.	Short-term Clinical Effects Of Cisplatin Combined With Temozolomide In Treatment Of Gliomas With MGMT Gene Promotor Methylation Positive After Surgery
177.	Efficacy Of Temozolomide Combined With Methotrexate In The Treatment Of Recurrent Central Nervous System Lymphoma After Operation
178.	Mechanism Of Anticancer Activity Of Cimicifuga Natural Product KY17 And The DNA Adducts Of Temozolomide Analogs
179.	Experimental Study On The Effect Of MTOR Inhibitor Everolimus Combined With Temozolomide On Autophagy In Malignant Glioma Cell
180.	Methylation-controlled J Protein Regulate Temozolomide Resistance Through ATM/Chk2-dependent Pathway In Glioblastoma
<<First <Prev Next> Last>> Jump to